摘要
目的分析血清幽门螺杆菌抗体联合胃蛋白酶原检测在胃癌筛查中价值。方法分析256例胃部不适就诊的患者其血清幽门螺旋杆菌、胃蛋白酶原及病理诊断之间的关系。结果幽门螺旋杆菌抗体及PG均阴性107例中无胃癌案例,单纯幽门螺旋杆菌抗体阳性84例有胃癌1例。单纯PG阳性46例胃癌8例。幽门螺旋杆菌抗体及PG均阳性29例中胃癌13例。不同幽门螺旋杆菌抗体、PG表型中病理诊断结构组成对比,差异具有统计学意义(P<0.05)。结论以PG阳性为主指标、幽门螺旋杆菌抗体阳性为辅助诊断指标,可进一步扩大胃癌诊断的敏感性。
Objective To evaluate the value of serum pepsinogen combined with Helicobacter pylori antibody detection in the screening of gastric cancer. Methods To analyze the relationship between 256 cases of stomach discomfort in patients with serum pepsinogen, Helicobacter pylori and pathological diagnosis. Results Helicobacter pylori antibody and PG were negative in 107 cases of non gastric cancer cases, only84 cases of Helicobacter pylori antibody positive in 1 cases of gastric cancer. PG positive in 46 cases of gastric cancer in 8 cases. Helicobacter pylori antibody and PG were positive in 29 cases of gastric cancer in 13 cases. There were differences in the pathological diagnosis of different Helicobacter pylori antibody and PG phenotype（P〈0.05）. Conclusion PG positive index and Helicobacter pylori antibody positive were the auxiliary diagnostic indexes, which can further expand the diagnostic sensitivity of gastric cancer.
出处
《中国卫生标准管理》
2017年第2期122-123,共2页
China Health Standard Management
关键词
胃癌筛查
幽门螺旋菌
抗体
胃蛋白酶原
screening for gastric cancer
Helicobacter pylori
antibody
pepsinogen
